CA 19-9 (Pancreatic/GI Cancer)

Marker for pancreatic and GI cancers

1/22Providers
Cancer ScreeninCategory
<37 U/mLReference

Limited Availability

1 providers include this

Category

Cancer Screening Markers

Reference Range

<37 U/mL

What is CA 19-9 (Pancreatic/GI Cancer)?

Marker for pancreatic and GI cancers

Why It Matters

Elevated in pancreatic cancer and other GI malignancies. Also increased in pancreatitis and biliary obstruction. Used for monitoring treatment.

Reference Range: <37 U/mL

Which Providers Test CA 19-9 (Pancreatic/GI Cancer)?

Function
Included in panel

Full Provider Comparison

ProviderIncludesAnnual CostBiomarkers
SuperpowerSuperpower—$199100+ (150 with ratios)
WHOOP Advanced LabsWHOOP Advanced Labs—$34965
Labcorp OnDemandLabcorp OnDemand—$39830+
Life ExtensionLife Extension—$48640+
EverlywellEverlywell—$46883
Mito HealthMito Health—$349100+
InsideTrackerInsideTracker—$68054
Function HealthFunction Health✓$365100+
Marek Health BaseMarek Health Base—$25065
Marek Health ComprehensiveMarek Health Comprehensive—$49570+
Marek Health CompleteMarek Health Complete—$895100+
Marek Health ExecutiveMarek Health Executive—$1950150+
BlueprintBlueprint—$399100+
Quest HealthQuest Health—$Varies75+
Empirical HealthEmpirical Health—$190100+
Oura Health PanelsOura Health Panels—$9950
SiPhox HealthSiPhox Health—$12560
Hims Labs BaseHims Labs Base—$19950
Hims Labs AdvancedHims Labs Advanced—$499120+
HealthspanHealthspan—$418880+
Vitality Blueprint StandardVitality Blueprint Standard—$37585
Vitality Blueprint EliteVitality Blueprint Elite—$700129

Ready to Test CA 19-9 (Pancreatic/GI Cancer)?

1 providers include this biomarker in their panels

View Top ProviderCompare All Providers

Frequently Asked Questions

What does CA 19-9 (Pancreatic/GI Cancer) test for?
CA 19-9 (Pancreatic/GI Cancer) is a cancer screening markers biomarker. Marker for pancreatic and GI cancers The normal reference range is <37 U/mL.
Which providers include CA 19-9 (Pancreatic/GI Cancer)?
1 of 22 providers include this test:Function.
How often should I test CA 19-9 (Pancreatic/GI Cancer)?
For most people, testing 2-4 times per year is recommended to establish baseline levels and track trends. Consult your healthcare provider for personalized recommendations.
What is the optimal range?
The standard reference range is <37 U/mL. Many functional medicine practitioners recommend tighter optimal ranges for peak health. Your ideal range may vary based on age, sex, and health goals.
Why is CA 19-9 (Pancreatic/GI Cancer) important?
Elevated in pancreatic cancer and other GI malignancies. Also increased in pancreatitis and biliary obstruction. Used for monitoring treatment.

Medical Disclaimer

This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider about your specific health needs.